Illumina's CFO, Joydeep Goswami, to depart in June, replaced by Ankur Dhingra.
Illumina, a gene sequencing company, announced that its CFO, Joydeep Goswami, will leave in June, replaced by Ankur Dhingra, previously CFO at Summit Therapeutics. Goswami, with 20+ years of life sciences industry experience, has been Illumina's CFO since early 2023. The company reaffirmed its Q1 and full-year 2024 forecast despite earlier predicting flat annual core business revenue due to low demand for genetic testing.
April 09, 2024
6 Articles